Healthcare Technologies (NASDAQ: MRM) inks Tools for Humanity agreement
Rhea-AI Filing Summary
Healthcare Technologies Inc. reported that its Master Service Agreement with Tools for Humanity and World Foundation became effective on February 2, 2026. The partnership is tied to deployment of Orbs biometric devices in Japan.
The company currently has Orbs at more than 150 locations, with cumulative authentications exceeding 20,000. Based on current performance, if it expands to about 3,000 locations nationwide in Japan, Healthcare Technologies estimates it could generate approximately USD 39 million (about JPY 6.10 billion) in income before income taxes over the next two years under the agreement, though this projection is forward-looking and subject to risks.
Positive
- None.
Negative
- None.
Insights
New AI-focused service agreement with contingent $39M projection over two years.
Healthcare Technologies Inc. now has an effective Master Service Agreement with Tools for Humanity and World Foundation, anchored on Orb-based authentication services. This formalizes a commercial framework around deployments already underway at more than 150 locations in Japan.
The company reports over 20,000 cumulative authentications, using this performance to model potential income. If it scales Orb installations to roughly 3,000 locations nationwide, it estimates about
These figures are explicitly forward-looking and depend on achieving aggressive expansion targets and sustaining authentication volumes. Future company filings and updates on location rollout and usage levels will clarify how closely actual results track this projection and how the agreement contributes to overall growth.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February, 2026
Commission File Number 001-39809
MEDIROM HEALTHCARE TECHNOLOGIES INC.
(Translation of registrant’s name into English)
2-3-1 Daiba, Minato-ku
Tokyo 135-0091, Japan
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form 20-F ☐ Form 40-F
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Issuance of Press Release
On February 26, 2026, MEDIROM Healthcare Technologies Inc. (the “Company”) issued a press release announcing that the Master Service Agreement (the “Agreement”) with Tools for Humanity (co-founded by Sam Altman and Alex Blania) and World Foundation became effective on February 2, 2026. The release stated that, based on current authentication performance, if the Company expands to approximately 3,000 locations nationwide in Japan, it could generate income of approximately USD 39 million over the next two years. A copy of the press release is furnished as Exhibit 99.1 hereto.
The information furnished in this report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.
EXHIBIT INDEX
Exhibit No. | | Description |
99.1 | | Press release of the Company |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MEDIROM HEALTHCARE TECHNOLOGIES INC. | |
Date: February 26, 2026 | | |
| By: | /s/ Fumitoshi Fujiwara |
| | Name: Fumitoshi Fujiwara |
| | Title: Chief Financial Officer |
Exhibit 99.1
MEDIROM Launches Partnership with Tools for Humanity in February;
Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations
Tokyo, Japan – February 26, 2026 – MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the Nasdaq Capital Market: NASDAQ: MRM) announced that the Master Service Agreement (the “Agreement”) entered into with Tools for Humanity (co-founded by Sam Altman and Alex Blania) and World Foundation became effective on February 2, 2026.
Currently, Orbs are installed at more than 150 locations, primarily at relaxation studios “Re.Ra.Ku” operated by the MEDIROM Group. Cumulative authentications have surpassed 20,000 to date.
Based on the current authentication performance levels, if MEDIROM achieves its target of expanding to approximately 3,000 locations nationwide in Japan, the Company estimates that it could generate income before income taxes of approximately USD 39 million (approximately JPY 6.10 billion*) over the next two years under the Agreement.
*Exchange rate of USD 1 = JPY 156.36 as of February 25, 2026 (Source: Bloomberg)
■ About Tools for Humanity
Tools for Humanity (TFH) is a global technology company established to build for humans in the age of AI. Founded by Sam Altman and Alex Blania, it led the initial development of World Network and operates World App. Tools for Humanity Corporation is headquartered in San Francisco, California and Munich, Germany. To learn more, visit: https://www.toolsforhumanity.com/
■ About MEDIROM Group
MEDIROM Group operates approximately 300 wellness salons under the “Re.Ra.Ku®” brand nationwide. Since 2015, we have expanded into HealthTech, offering on-demand training apps like Lav® for specific health guidance and lifestyle improvement programs. In 2020, we started manufacturing the 24/7 recharge-free smart tracker “MOTHER Bracelet®,” which is now used in REMONY, our remote monitoring system for various industries including caregiving, transportation, construction, and manufacturing.
NASDAQ Symbol: MRM
Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan
Website: https://medirom.co.jp/en
Contact: ir@medirom.co.jp
■ Forward-Looking Statements Regarding MEDIROM
These forward-looking statements are based on MEDIROM’s current expectations, assumptions and internal projections and are subject to various known and unknown risks and uncertainties. They do not represent guaranteed future income or results, nor do they constitute binding contractual commitments. Actual results may differ materially from those expressed or implied by these
forward-looking statements.
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “designate,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:
| ● | MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives, including the full-scale adoption of World ID and deployment of Orb authentication terminals across 3,000 locations on the planned timeline, the establishment of appropriate training and operational oversight, Orb production capacity and delivery schedules, and achieving its targeted number of verifications; |
| ● | the MSA being early terminated by the World parties for convenience or any other reason; |
| ● | Changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets; |
| ● | MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment; |
| ● | the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies; |
| ● | MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property; |
| ● | MEDIROM’s ability to raise additional capital on acceptable terms or at all; |
| ● | MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments; |
| ● | changes in consumer preferences and MEDIROM’s competitive environment; |
| ● | MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and |
| ● | the regulatory environment in which MEDIROM operates. |
More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.
FAQ
What did Healthcare Technologies Inc. (MRM) disclose in its February 2026 Form 6-K?
How much income could Healthcare Technologies Inc. (MRM) earn from the Tools for Humanity agreement?
What expansion is required for Healthcare Technologies Inc. (MRM) to reach the projected $39 million income?
What are the current Orb deployment metrics reported by Healthcare Technologies Inc. (MRM)?
Who are Tools for Humanity and World Foundation in Healthcare Technologies Inc.’s new agreement?
How does Healthcare Technologies Inc. (MRM) describe the risks around its $39 million income projection?
Filing Exhibits & Attachments
1 documentPress Releases
